GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis
Authors:
- Ronald E. MyersRMRonald E. Myers
- Hushan YangHYHushan Yang
- Zhinan ChenZCZhinan Chen
- 1 July 2011
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 47 (11) , 1699-1707
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Estimates of cancer incidence and mortality in Europe in 2008European Journal of Cancer, 2010
- Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor–Targeted Therapy in Metastatic Colorectal CancerJNCI: Journal of the National Cancer Institute, 2009
- The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancerNature Genetics, 2009
- Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neckCarcinogenesis, 2009
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990sEuropean Journal of Cancer, 2008
- Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21Nature Genetics, 2008
- A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3Nature Genetics, 2008
- Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer riskNature Genetics, 2007
- A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer riskNature Genetics, 2007
- Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferationProceedings of the National Academy of Sciences, 2006